文献速递神经MR

验证DWI与DSC-MRI的PSR优化协议联合应用在高级别胶质瘤、转移瘤与淋巴瘤鉴别中的价值

Validation of combined use of DWI and percentage signal recovery-optimized protocol of DSC-MRI in differentiation of high-grade glioma, metastasis, and lymphoma.
PubMed 文献 · Neuroradiology · 2020-08-21

本研究回顾性评估99例孤立性强化脑肿瘤(60例高级别胶质瘤、24例转移瘤、15例原发性中枢神经系统淋巴瘤)治疗前DWI与PSR优化协议DSC-MRI的参数鉴别能力。肿瘤核心PSR鉴别三类肿瘤表现最佳,PCNSL vs 其他AUC为0.979,HGG vs 转移瘤AUC为0.947;ADC仅在肿瘤核心有助于区分PCNSL与其他(AUC=0.897)。作者认为PSR优化协议所得PSR似乎是初始诊断鉴别的最重要参数,并提示需要综合DSC-MRI协议以同时提供PSR敏感性与CBV准确性。

要点

  • 肿瘤核心PSR鉴别三类肿瘤最佳:PCNSL vs 其他AUC 0.979,HGG vs 转移瘤AUC 0.947。
  • ADC仅在肿瘤核心有助于区分PCNSL与其他,AUC=0.897。
  • PSR优化协议(TR/TE=1500/30 ms,翻转角90°,无预载)所得PSR不同于CBV优化协议(预载、中等翻转角)。

核心结论

  • PSR优化协议所得肿瘤核心PSR似乎是初始诊断时鉴别HGG、转移瘤与PCNSL的最重要参数。
  • 该特性使PSR具有重要价值,并提示需要综合DSC-MRI协议以同时提供PSR敏感性与CBV准确性,例如在CBV优化协议前使用PSR优化协议的预载。

研究设计与样本

  • 回顾性评估治疗前99例孤立性强化脑肿瘤,包括60例HGG、24例转移瘤、15例PCNSL。
  • DSC-MRI采用PSR优化协议(TR/TE=1500/30 ms,翻转角=90°,无预载),并采集DWI。
  • 测量肿瘤核心rCBV、PSR、ADC及瘤周水肿rCBV、ADC,采用单因素方差分析比较差异,ROC曲线分析评估诊断性能。

诊断标准与关键数值

  • 肿瘤核心PSR鉴别PCNSL与其他肿瘤的AUC为0.979。
  • 肿瘤核心PSR鉴别HGG与转移瘤的AUC为0.947。
  • 肿瘤核心ADC区分PCNSL与其他肿瘤的AUC为0.897。

临床应用与阅片要点

  • 作者认为PSR优化协议所得PSR似乎是初始诊断时鉴别HGG、转移瘤与PCNSL的最重要参数。
  • 作者提示需要综合DSC-MRI协议以同时提供PSR敏感性与CBV准确性,例如在CBV优化协议前使用PSR优化协议的预载。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: With conventional MRI, it is often difficult to effectively differentiate between contrast-enhancing brain tumors, including primary central nervous system lymphoma (PCNSL), high-grade glioma (HGG), and metastasis. This study aimed to assess the discrimination ability of the parameters obtained from DWI and the percentage signal recovery- (PSR-) optimized protocol of DSC-MRI between these three tumor types at an initial step.

METHODS: DSC-MRI using a PSR-optimized protocol (TR/TE = 1500/30 ms, flip angle = 90°, no preload) and DWI of 99 solitary enhancing tumors (60 HGGs, 24 metastases, 15 PCNSLs) were retrospectively assessed before treatment. rCBV, PSR, ADC in the tumor core and rCBV, and ADC in peritumoral edema were measured. The differences were evaluated using one-way ANOVA, and the diagnostic performance was evaluated using ROC curve analysis.

RESULTS: PSR in the tumor core showed the best discriminating performance in differentiating these three tumor types with AUC values of 0.979 for PCNSL vs. others and 0.947 for HGG vs. metastasis. The ADC was only helpful in the tumor core and distinguishing PCNSLs from others (AUC = 0.897).

CONCLUSION: Different from CBV-optimized protocols (preload, intermediate FA), PSR derived from the PSR-optimized protocol seems to be the most important parameter in the differentiation of HGGs, metastases, and PCNSLs at initial diagnosis. This property makes PSR remarkable and carries the need for comprehensive DSC-MRI protocols, which provides PSR sensitivity and CBV accuracy together, such as the preload use of the PSR-optimized protocol before the CBV-optimized protocol.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Cindil E, Sendur HN, Cerit MN, et al. Validation of combined use of DWI and percentage signal recovery-optimized protocol of DSC-MRI in differentiation of high-grade glioma, metastasis, and lymphoma. Neuroradiology. 2020. PMID: 32821962. doi:10.1007/s00234-020-02522-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。